CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 261 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,140,000 | +1400.0% | 88,892 | +568.6% | 0.10% | +1385.7% |
| Q2 2021 | $76,000 | -58.7% | 13,295 | -78.6% | 0.01% | -78.1% |
| Q3 2020 | $184,000 | +360.0% | 62,022 | +478.3% | 0.03% | +700.0% |
| Q4 2019 | $40,000 | -93.0% | 10,725 | -90.5% | 0.00% | -87.9% |
| Q1 2019 | $574,000 | +185.6% | 112,568 | +7.7% | 0.03% | +200.0% |
| Q4 2018 | $201,000 | +204.5% | 104,506 | +523.4% | 0.01% | +266.7% |
| Q4 2017 | $66,000 | -14.3% | 16,764 | -44.8% | 0.00% | -25.0% |
| Q3 2017 | $77,000 | – | 30,372 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |